- Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thom DH, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 161: 618–25.
- Grayston JT, Wang SP, Kuo CC, Campbell LA. Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis 1989d; 8: 191–202.
- Darougar S, Forsey T, Brewerton DA, Rogers KL. Prevalence of antichlamydial antibody in London blood donors. Br J Vener Dis 1980; 56: 404–7.
- Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infection 1992; 25: 27–34.
- Hammerschlag MR, Chirgwin K, Roblin PM, Gelling M, Dumornay W, Mandel L, et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992; 14: 178–82.
- Falck G, Heyman L, Gnarpe J, Gnarpe H. Chlamydia pneumoniae and chronic pharyngitis. Scand J Infect Dis 1995; 27: 179–82.
- Falck G, Engstrand I, Gad A, Gnarpe J, Gnarpe H, Laurila A. Demonstration of Chlamydia pneumoniae in patients with chronic pharyngitis. Scand J Infect Dis 1997; 29: 585–9.
- Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Int Med 1992; 116: 273–8.
- Davidson M, Kuo CC, Middaugh JP, Campbell LA, Wang SP, Newman III WP, et al. Confirmed previous infection with Chlamydia pneumoniae and its presence in early coronary atherosclerosis. Circulation 1998; 98: 628–33.
- Toss H, Gnarpe J, Gnarpe H, Siegbahn A, Lindahl B, Venge P, Wallentin L. Increased fibrinogen and C-reactive protein levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease. Eur Heart J 1998; 19: 570–7.
- Gabriel AS, Gnarpe H, Gnarpe J, Hallander H, Nyqvist O, Martinsson A. The prevalence of chronic Chlamydia pneumoniae infection as determined by polymerase chain reaction in pharyngeal samples from patients with ischemic heart disease. Eur Heart J 1998; 19: 1321–7.
- Wang SP, Grayston JT. Immunologic relationship between genital TRIC, lymphogranuloma venereum and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol 1970; 70: 367–74.
- Lund-Olsen I, Lundback A, Gnarpe J, Gnarpe H. Prevalence of specific antibodies to Chlamydia pneumoniae in children with acute respiratory infections. Acta Paediatr 1994; 83: 1143–5.
- Normann E, Gnarpe J, Gnarpe H, Wettergren B. Chlamydia pneumoniae in children with acute respiratory tract infections. Acta Paediatr 1998; 87: 23–7.
- Falck G, Heyman L, Gnarpe J, Gnarpe H. Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis. Scand J Infect Dis 1994; 26: 179–87.
- The Nordic Atypical Pneumonia Study Group. Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. J Antimicrob Chemother 1997; 39: 499–508.
- Karvonen M, Tuomilehto J, Pitkaniemi J, Saikku P. The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972–1987. Epidemiol Infect 1993; 110: 349–60.
- Gnarpe H, Gnarpe J. Increasing prevalence of specific antibodies to Chlamydia pneumoniae in Sweden. Lancet 1993; 341: 381.
Scandinavian Journal of Infectious Diseases
Volume 31, 1999 - Issue 1